TRACERS

IMAGING TRACERS

We provide our clients with highest quality radiopharmaceuticals, reliably delivered with care. We take pride in our record of having a 99% cyclotron uptime, allowing us to successfully deliver more than 675,000 doses annually, servicing imaging centers from coast-to-coast.

F18-Fludeoxyglucose

18F-FDG is indicated for positron emission tomography (PET) imaging used in oncology, neurology and cardiology

PYLARIFY®

PYLARIFY (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

Neuraceq®

Neuraceq® is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline.

DetectNetTM

Detectnet is indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients.

NETSPOT

NETSPOT, after radiolabeling with Ga 68, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.

F18-Sodium Fluoride

F18-NaF is a radioactive diagnostic agent for positron emission tomography (PET) indicated for imaging of bone to define areas of altered osteogenic activity.

N13-Ammonia

N13-Ammonia is a radioactive diagnostic agent for Positron Emission Tomography (PET) indicated for diagnostic PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease.

FIND A RADIOPHARMACY LOCATION

Dedicated to providing reliable, high quality products and cutting-edge technologies